Editorial: Microbiome in IBD: From Composition to Therapy, Volume II

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II

Bibliographic Details
Main Authors:	Ning-Ning Liu, Peijian He, Zhanju Liu, Ruixin Zhu, Yinglei Miao, Chenggong Yu, Lixin Zhu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Pharmacology
Subjects:	inflammatory bowel disease microbiome ulcerative colitis Crohn’s disease interaction
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1184269/full

Similar Items

Editorial: Microbiome in IBD: From Composition to Therapy
by: Ruixin Zhu, et al.
Published: (2021-06-01)

Identifying Microbiome Dynamics in Pediatric IBD: More than a Family Matter
by: Nikolas Dovrolis, et al.
Published: (2023-07-01)

The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?
by: Khalid Elmaghrawy, et al.
Published: (2021-01-01)

The Interplay Between Use of Biological Therapies, Psychological State, and the Microbiome in IBD
by: Paris Tavakoli, et al.
Published: (2022-07-01)

The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1
by: Floris Imhann, et al.
Published: (2019-01-01)

Current status of IBD and surgery of Crohn's disease in Thailand
by: Woramin Riansuwan, et al.
Published: (2021-09-01)

Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID‐19 pandemic
by: Khoon Lin Ling, et al.
Published: (2020-06-01)

Obesity in inflammatory bowel disease: A review of its role in the pathogenesis, natural history, and treatment of IBD
by: Amanda M Johnson, et al.
Published: (2021-01-01)

IBD and Motherhood: A Journey through Conception, Pregnancy and Beyond
by: Antonio M. Caballero-Mateos, et al.
Published: (2023-09-01)

Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases
by: Hala Elzayat, et al.
Published: (2023-07-01)

Mining the Microbiome and Microbiota-Derived Molecules in Inflammatory Bowel Disease
by: Matthijs Bekkers, et al.
Published: (2021-10-01)

Perturbation of the Human Microbiome as a Contributor to Inflammatory Bowel Disease
by: Bayan Missaghi, et al.
Published: (2014-06-01)

The IBD-FITT study — moderate-intensity exercise for patients with inflammatory bowel disease with moderate disease activity: an open-label randomized controlled trial
by: Ken Lund, et al.
Published: (2023-11-01)

Differences in Dietary Patterns of Adolescent Patients with IBD
by: Justyna Kikut, et al.
Published: (2021-09-01)

Systematic Review: The Gut Microbiome and Its Potential Clinical Application in Inflammatory Bowel Disease
by: Laila Aldars-García, et al.
Published: (2021-04-01)

Disease-Related Knowledge in New Zealand Children with Inflammatory Bowel Disease (IBD) and Their Parents
by: Laura Appleton, et al.
Published: (2021-01-01)

Components of the Fiber Diet in the Prevention and Treatment of IBD—An Update
by: Katarzyna Ferenc, et al.
Published: (2022-12-01)

Overcoming Workplace Disability in IBD Patients: An Observational Study
by: Emma Paulides, et al.
Published: (2020-03-01)

Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland
by: Grażyna Markiewicz-Łoskot, et al.
Published: (2023-06-01)

Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A review of 740 patients in Fars province, Southern Iran
by: Murat Kekilli, et al.
Published: (2013-12-01)

Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review
by: Susanna Meade, et al.
Published: (2023-12-01)

Improved Healthcare Access Reduces Requirements for Surgery in Indigent IBD Patients Using Biologic Therapy: A ‘Safety-Net’ Hospital Experience
by: Phillip Gu, et al.
Published: (2022-07-01)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
by: Tyler Atagozli, et al.
Published: (2023-04-01)

IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC
by: Sheng Gao, et al.
Published: (2022-04-01)

Predictive biomarkers for anti-TNF alpha therapy in IBD patients
by: Manoj Kumar, et al.
Published: (2024-03-01)

Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD
by: Adrian Martyniak, et al.
Published: (2021-12-01)

Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn’s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets
by: Babak Khorsand, et al.
Published: (2022-10-01)

Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
by: Arshdeep Singh, et al.
Published: (2023-07-01)

Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD
by: Hong Liu, et al.
Published: (2019-11-01)

Omics and Multi-Omics in IBD: No Integration, No Breakthroughs
by: Claudio Fiocchi
Published: (2023-10-01)

The Usefulness of Serum Vitamin D Levels in the Assessment of IBD Activity and Response to Biologics
by: Marco Valvano, et al.
Published: (2021-01-01)

Biologic therapy is associated with a mild decrease in the rate of hospitalizations in pediatric IBD
by: Gil Berkovitch, et al.
Published: (2021-02-01)

A Retrospective Analysis of Clinical Features and Treatment of the Inflammatory Bowel Disease in China
by: Shao S, et al.
Published: (2022-06-01)

Machine Learning Based Microbiome Signature to Predict Inflammatory Bowel Disease Subtypes
by: Jose Liñares-Blanco, et al.
Published: (2022-05-01)

Telemedicine Is an Effective Tool to Monitor Disease Activity in IBD Patients in the COVID-19 Era: A Single Centre Experience Based on Objective Data
by: Emanuele Sinagra, et al.
Published: (2022-03-01)

Gut Microbiome in Inflammatory Bowel Disease: Role in Pathogenesis, Dietary Modulation, and Colitis-Associated Colon Cancer
by: John Gubatan, et al.
Published: (2022-07-01)

Substantiation of application and estimation of efficacy of probiotics at inflammatory bowel diseases
by: Ye. A. Poluektova, et al.
Published: (2024-03-01)

Homeostasis and Dysbiosis of the Intestinal Microbiota: Comparing Hallmarks of a Healthy State with Changes in Inflammatory Bowel Disease
by: Jasminka Talapko, et al.
Published: (2022-12-01)

All are Equal, Some are More Equal: Targeting IL 12 and 23 in IBD – A Clinical Perspective
by: Jefremow A, et al.
Published: (2020-11-01)

Gene Identification in Inflammatory Bowel Disease via a Machine Learning Approach
by: Gerardo Alfonso Perez, et al.
Published: (2023-06-01)